Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + Dexmedetomidine for PONV in Laparoscopic Hysterectomy
NCT03788018Completed
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and dexmedetomidine in postoperative nausea and vomiting (PONV) (2 arms). Primary endpoints: Incidence of postoperative nausea and vomiting (0-2 hours), Incidence of postoperative nausea and vomiting (2-24 hours) and 1 more. Started Jan 2018; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03788018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788018.